0.741
price up icon0.82%   0.006
after-market After Hours: .75 0.009 +1.21%
loading
Nautilus Biotechnology Inc stock is traded at $0.741, with a volume of 58,146. It is up +0.82% in the last 24 hours and up +6.60% over the past month. Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
See More
Previous Close:
$0.735
Open:
$0.7531
24h Volume:
58,146
Relative Volume:
0.20
Market Cap:
$93.48M
Revenue:
-
Net Income/Loss:
$-70.78M
P/E Ratio:
-1.3232
EPS:
-0.56
Net Cash Flow:
$-61.27M
1W Performance:
-1.03%
1M Performance:
+6.60%
6M Performance:
-62.95%
1Y Performance:
-73.54%
1-Day Range:
Value
$0.7409
$0.7569
1-Week Range:
Value
$0.71
$0.772
52-Week Range:
Value
$0.66
$3.09

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name
Name
Nautilus Biotechnology Inc
Name
Phone
206-333-2001
Name
Address
2701 EASTLAKE AVE EAST, SEATTLE
Name
Employee
134
Name
Twitter
Name
Next Earnings Date
2024-10-29
Name
Latest SEC Filings
Name
NAUT's Discussions on Twitter

Compare NAUT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
NAUT
Nautilus Biotechnology Inc
0.741 92.72M 0 -70.78M -61.27M -0.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
476.95 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.39 60.56B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.64 42.41B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
575.42 34.96B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.83 31.99B 3.81B -644.79M -669.77M -6.24

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-05-24 Downgrade Goldman Neutral → Sell
Jun-27-24 Initiated Guggenheim Buy
Jun-03-24 Resumed Jefferies Hold
Jan-06-22 Initiated Morgan Stanley Equal-Weight
Nov-02-21 Initiated Cowen Outperform
Aug-04-21 Initiated Goldman Neutral
Jul-13-21 Initiated Jefferies Buy
View All

Nautilus Biotechnology Inc Stock (NAUT) Latest News

pulisher
01:31 AM

Is Nautilus Biotechnology Inc. a good long term investmentTremendous gains - Autocar Professional

01:31 AM
pulisher
07:28 AM

What analysts say about Nautilus Biotechnology Inc. stockMarket-beating performance - jammulinksnews.com

07:28 AM
pulisher
Jul 22, 2025

What makes Nautilus Biotechnology Inc. stock price move sharplyProfessional Stock Screener - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Nautilus Biotechnology Inc. stock priceFree Capital Growth Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Nautilus Biotechnology Inc. stock performs during market volatilityWeekly Big Movers - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

Nautilus Biotechnology Inc. Stock Analysis and ForecastSkyrocketing returns - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

Nautilus Biotechnology to Announce Second Quarter 2025 Financial Results on July 31, 2025 - 富途牛牛

Jul 19, 2025
pulisher
Jul 18, 2025

What analysts say about Digital Ally Inc. stockSuperior risk-adjusted returns - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Best Stocks for Conservative Investors in India Expert Long Term StocksExplosive capital appreciation - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Macro Trends and Their Impact on Visaka Industries Limited (509055)Tremendous wealth creation - Jammu Links News

Jul 18, 2025
pulisher
Jul 15, 2025

What makes Stagwell Inc. stock price move sharplyHigh Reward Swing Trades - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why HLXCP stock attracts strong analyst attentionOptimized Return Investment Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why TSHA stock attracts strong analyst attentionWeekly Big Movers - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Nautilus Biotechnology Inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Veris Residential Inc. stock attracts strong analyst attentionExplosive Growth Potential - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Nautilus Biotechnology's Q2 2025: Can Proteomics Innovation Drive the Next Phase of Growth? - AInvest

Jul 15, 2025
pulisher
Jul 15, 2025

Nautilus Biotechnology, Inc. to Report Second Quarter 2025 Financial Results and Host Webcast Conference Call - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

What makes L.B. Foster Company stock price move sharplyDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ARAY stock performs during market volatilityFree Access to Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why GGAL stock attracts strong analyst attentionRisk Aware High Growth Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

hpepe(hero pepe) price forecastProven Win Setups - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Nautilus Biotechnology (NASDAQ:NAUT) Trading Down 7.5% – Should You Sell? - Defense World

Jul 11, 2025
pulisher
Jul 08, 2025

The Next Generation of Proteome Analysis - the-scientist.com

Jul 08, 2025
pulisher
Jun 27, 2025

Insiders of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) have had a great week after last week's US$12m gain and they haven't stopped buying - Yahoo Finance

Jun 27, 2025
pulisher
Jun 26, 2025

EDGE(dadi) Price TodaySecure Your Capital Strategy - newser.com

Jun 26, 2025
pulisher
Jun 14, 2025

Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLC - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Home Product Center Public (OTCMKTS:HPCRF) Trading Up 20.5% – Should You Buy? - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Bought by Jane Street Group LLC - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Citadel Advisors LLC Raises Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer - Business Wire

Jun 02, 2025
pulisher
May 30, 2025

Northern Trust Corp Sells 32,695 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 30, 2025
pulisher
May 27, 2025

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire

May 27, 2025

Nautilus Biotechnology Inc Stock (NAUT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$22.87
price up icon 4.91%
$36.01
price down icon 0.25%
$103.44
price up icon 0.51%
$28.01
price up icon 5.54%
$114.60
price up icon 2.84%
biotechnology ONC
$294.83
price down icon 0.26%
Cap:     |  Volume (24h):